Compare RITM & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RITM | TFX |
|---|---|---|
| Founded | 2011 | 1943 |
| Country | United States | United States |
| Employees | 6045 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.6B |
| IPO Year | N/A | 1994 |
| Metric | RITM | TFX |
|---|---|---|
| Price | $9.03 | $106.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 8 |
| Target Price | $14.56 | ★ $140.29 |
| AVG Volume (30 Days) | ★ 10.8M | 783.4K |
| Earning Date | 04-24-2026 | 04-30-2026 |
| Dividend Yield | ★ 11.40% | 1.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | N/A | $46.78 |
| Revenue Next Year | $5.52 | $3.86 |
| P/E Ratio | $10.21 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.43 | $100.18 |
| 52 Week High | $12.74 | $142.96 |
| Indicator | RITM | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 30.98 | 40.28 |
| Support Level | N/A | $102.03 |
| Resistance Level | $11.24 | $108.01 |
| Average True Range (ATR) | 0.31 | 2.92 |
| MACD | -0.05 | -1.04 |
| Stochastic Oscillator | 35.63 | 8.12 |
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.